The Oncology Revenue Reality
Oncology reimbursement is drug-intensive and compliance-sensitive. Small unit reporting errors can result in significant revenue loss.
- J-code unit miscalculations
- Chemotherapy infusion time errors
- Biologic underpayment
- Prior authorization failures
- Medical necessity denials
- Diagnosis-to-drug mismatch
- JW/JZ modifier errors for drug wastage
- Radiation therapy billing discrepancies
- High-dollar AR tied to specialty medications
Chemotherapy & Biologic Coding Precision (CCP)
- J-code unit accuracy
- Infusion and hydration time compliance
- JW/JZ modifier governance
- Add-on infusion code integrity
- Diagnosis alignment for medical necessity
Target Outcome: Reduced drug-related denials and improved first-pass acceptance.
Pre-Treatment Authorization & Coverage Controls (FIO + EAE)
- Prior authorization validation
- Coverage confirmation for specialty therapies
- Diagnosis-to-treatment alignment
- Frequency and benefit monitoring
Target Outcome: Fewer reimbursement disruptions for high-cost therapies.
High-Dollar AR Prioritization (AAF)
- Smart triage of high-value claims
- Payer-specific appeal playbooks
- Escalation ladder for chemotherapy disputes
- AR > 90 monitoring by J-code and CPT category
Target Outcome: Faster recovery of aging high-dollar claims.
Drug-Level Reimbursement Intelligence (PRL)
- Underpayment trends by J-code
- Reimbursement variance by payer
- Denial clustering by drug category
- Radiation therapy reimbursement patterns
- Appeal overturn rates on high-cost therapies
Target Outcome: Visibility into recurring oncology revenue leakage.
Measurable Performance Targets
- 8–18% lift in net collections
- 15–30% reduction in drug-related denials
- 25–40% reduction in AR > 90
- 95–98% first-pass claim acceptance
- Faster appeal resolution on high-cost therapies
Compliance & Infrastructure
- HIPAA-compliant workflows with BAA signed prior to PHI exchange
- Integration with major EHR platforms including Epic, Cerner, Athenahealth, NextGen, eClinicalWorks and others
- Cybersecurity oversight via Redfort Technologies
- U.S.-based nationwide operations
Are Your Chemotherapy and Biologic Claims Being Reimbursed at Full Contracted Rates?
Schedule a specialized Oncology Revenue Audit and identify how coding accuracy, documentation gaps, and denial patterns are affecting your claims, AR performance, and net collections.
Schedule a FREE Audit Now